Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Cancer Res. 2010 Nov 23;70(23):10002–10011. doi: 10.1158/0008-5472.CAN-10-2606

Figure 3.

Figure 3

Direct inhibition of AKT does not increase GJIC. (A) The AKT inhibitor, AKTinbVII, was used to decrease phospho-AKT levels directly (10 μM), without a corresponding increase in GJIC (B). Similar to AKT inhibition with Wortmannin, slight decreases in GJIC were observed.